chrX-55009187-T-A
Variant summary
Our verdict is Benign. Variant got -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_000032.5(ALAS2):c.1757A>T(p.Tyr586Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000399 in 1,205,917 control chromosomes in the GnomAD database, including 1 homozygotes. There are 141 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000032.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALAS2 | NM_000032.5 | c.1757A>T | p.Tyr586Phe | missense_variant | 11/11 | ENST00000650242.1 | NP_000023.2 | |
ALAS2 | NM_001037968.4 | c.1718A>T | p.Tyr573Phe | missense_variant | 11/11 | NP_001033057.1 | ||
ALAS2 | NM_001037967.4 | c.1646A>T | p.Tyr549Phe | missense_variant | 10/10 | NP_001033056.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALAS2 | ENST00000650242.1 | c.1757A>T | p.Tyr586Phe | missense_variant | 11/11 | NM_000032.5 | ENSP00000497236 | P1 | ||
ALAS2 | ENST00000396198.7 | c.1718A>T | p.Tyr573Phe | missense_variant | 11/11 | 5 | ENSP00000379501 | |||
ALAS2 | ENST00000335854.8 | c.1646A>T | p.Tyr549Phe | missense_variant | 10/10 | 2 | ENSP00000337131 | |||
ALAS2 | ENST00000498636.1 | c.*55A>T | 3_prime_UTR_variant | 5/5 | 3 | ENSP00000495662 |
Frequencies
GnomAD3 genomes AF: 0.00185 AC: 206AN: 111072Hom.: 0 Cov.: 23 AF XY: 0.00171 AC XY: 57AN XY: 33298
GnomAD3 exomes AF: 0.000563 AC: 97AN: 172239Hom.: 0 AF XY: 0.000310 AC XY: 18AN XY: 58151
GnomAD4 exome AF: 0.000241 AC: 264AN: 1094794Hom.: 1 Cov.: 30 AF XY: 0.000205 AC XY: 74AN XY: 360564
GnomAD4 genome AF: 0.00195 AC: 217AN: 111123Hom.: 0 Cov.: 23 AF XY: 0.00201 AC XY: 67AN XY: 33359
ClinVar
Submissions by phenotype
not provided Uncertain:3Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Nov 30, 2016 | The Y586F variant has previously been reported as heterozygous in a single female patient with moderate congenital erythropoietic porphyria (To-Figueras et al., 2011). Functional analysis of Y586F found that it is assocaited with only a mild gain of function in vitro (To-Figueras et al., 2011). However, the NHLBI Exome Sequencing Project reports Y586F was observed in 31/3835 alleles from individuals of African-American background, indicating it may be a rare, benign variant in this population. The Y586F variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals. In silico analysis predicts this variant likely does not alter the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Jul 05, 2022 | - - |
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
X-linked sideroblastic anemia 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Developmental and epileptic encephalopathy, 36 Benign:1
Benign, criteria provided, single submitter | clinical testing | Dr.Nikuei Genetic Center | Jun 27, 2024 | - - |
X-linked erythropoietic protoporphyria Other:1
not provided, no classification provided | literature only | GeneReviews | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at